Publication Name	World Journal of Gastrointestinal Pharmacology and Therapeutics
Manuscript ID	30827
Country	Pakistan

Received	2016-10-20 10:01
Peer-Review Started	2016-10-22 23:50
To Make the First Decision	2016-12-01 09:04
Return for Revision	2016-12-01 10:08
Revised	2016-12-13 18:50
Second Decision	2016-12-20 15:49
Accepted by Journal Editor-in-Chief	2016-12-20 20:49
Accepted by Company Editor-in-Chief	2017-01-03 15:25
Articles in Press	2017-01-03 15:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2017-01-12 17:35
Publish the Manuscript Online	2017-01-20 16:40

ISSN	2150-5349 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Minireviews
Article Title	Update on clinical and research application of fecal biomarkers for gastrointestinal diseases
Manuscript Source	Invited Manuscript
All Author List	Imran Siddiqui, Hafsa Majid and Shahab Abid
Funding Agency and Grant Number
Corresponding Author	Shahab Abid, MBBS, PhD, FCPS, FRCP, FACG, Section of Gastroenterology, Department of Medicine, Aga Khan University, Stadium Road, P.O. Box 3500. Karachi 74800, Pakistan. shahb.abid@aku.edu
Key Words	Biomarkers; Gastrointestinal diseases; Inflammation; Lactoferrin; Calprotectin
Core Tip	There is a general inclination of clinicians as well as pathologists’ to consider fecal biomarkers due to its non-invasivity. There are multiple types of fecal biomarkers in clinical use and under exploration for potential clinical use in future. It includes biomarkers for evaluating inflammatory bowel disease (e.g., calpro-tectin, lactoferrin), for evaluating colorectal cancer, malabsor-ption and eosinophilic protein for allergic gastroin-testinal diseases. In this review we have analyzed the current status in terms of their practical utilization of fecal biomarkers with established indications and those which are under various stages of investigation.
Publish Date	2017-01-20 16:40
Citation	Siddiqui I, Majid H, Abid S. Update on clinical and research application of fecal biomarkers for gastrointestinal diseases. World J Gastrointest Pharmacol Ther 2017; 8(1): 39-46
URL	http://www.wjgnet.com/2150-5349/full/v8/i1/39.htm
DOI	http://dx.doi.org/10.4292/wjgpt.v8.i1.39

Full Article (PDF)	WJGPT-8-39.pdf
Full Article (Word)	WJGPT-8-39.doc
Manuscript File	30827-Review.docx
Answering Reviewers	30827-Answering reviewers.pdf
Audio Core Tip	30827-Audio core tip.m4a
Conflict-of-Interest Disclosure Form	30827-Conflict-of-interest statement.pdf
Copyright License Agreement	30827-Copyright assignment.pdf
Peer-review Report	30827-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	30827-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	30827-Scientific misconduct check.pdf
Scientific Editor Work List	30827-Scientific editor work list.pdf